Ginkgo Bioworks Holdings Inc Class (DNA)
R&D Expense Growth
-7.43%
Quarterly · Period ending:
DNA R&D Expense Growth
Latest reported-7.43%period ending
Latest reported-7.43%period ending
DNA Quarterly R&D Growth (QoQ) (0.00% → -7.43%)
Latest values, visible window
High-resolution chart · PNG
DNA r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -7.4319% | |
| -0.413% | |
| -27.7219% | |
| 29.9475% | |
| -24.7494% | |
| -7.1409% | |
| -0.8168% | |
| -42.6275% | |
| -1.6386% | |
| 16.592% | |
| -25.2927% | |
| 8.5804% | |
| -11.287% | |
| -10.2211% | |
| -30.7141% | |
| -9.8597% | |
| -10.3583% | |
| -67.1505% | |
| 1,757.8016% | |
| 1.9027% | |
| -12.6777% | |
| -2.6246% | |
| 69.6451% | |
| 11.7756% | |
| 6.7271% | |
| 0% |